Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
- Status
- COMPLETED
- Phase
- PHASE2
Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Trans-pulmonary Biomarkers in Pulmonary Hypertension
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Therapeutic Option for Hepatitis B and C: a French Cohort
- Status
- UNKNOWN
- Phase
- N/A
Effects of Ranolazine and Exercise on Daily Physical Activity Trial
- Status
- COMPLETED
- Phase
- PHASE4